The current medical treatment model, centered on a “one size fits all” approach, lacks precision. Personalized medicine, aiming for tailored treatment based on individual profiles, holds promise for optimal efficacy …
The medical 3D lab at Medisch Spectrum has become a recognized and permanent part of the organisation. It was founded in 2018 and is organized from the department of Medical …
Is the title of the presentation by Assistant Professor Veerle Bloemen, KU Leuven Campus Group T, where her research focuses on integrating biofabrication technologies into the production of cell-based implants …
Regardless of the cultivation system, one principle remains key: we need the plant to grow. Not only grow, but THRIVE. Let us take you through the five pillars we at …
Additive manufacturing offers new perspectives to mimic the complex architecture of bone, and develop advanced bone models and substitutes. Functionalization of the construct by biomimetic nanomaterials allows to reproduce the …
The Company’s mission is to create unique food ingredients by engineering plants with animal protein genes. Its purpose is to redefine the way the world produces animal-based food, for good …
Vertical farms offer the possibility to cultivate crops in a fully controlled environment regardless of the external climate and geographical location. This higher level of control for plant growth has …
The vision of INKplant H2020-funded project is the fusion/combination of different biomaterials, high resolution additive manufacturing technologies (lithographic ceramic manufacturing and 3D multi-material inkjet printing), and advanced simulation and biological …
Biomimicry, the practice of drawing inspiration from nature to solve complex technological challenges, has become a driving force behind technological advancement. By studying millions of years of evolution, researchers and …
Regardless of the cultivation system, one principle remains key: we need the plant to grow. Not only grow, but THRIVE. Let us take you through the five pillars we at …
